CLINICAL_TRIALS
trial_result
· 2023-07-12
Clinical Trial Update: Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID [Phase 3]
Summary
Phase 3 trial evaluating BT595 for primary immunodeficiency disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biotest | Conditions: Primary Immunodeficiency Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-07-12